Fundraising Fox

Biotech Startups

10,099 companies tagged Biotech, with their investors and founders.

RVL Pharmaceuticals

RVL Pharmaceuticals develops prescription and skincare products for ocular and aesthetic care, including its flagship prescription eye drop Upneeq (oxymetazoline hydrochloride ophthalmic solution) and the Upneeq Reveal Under Eye Complex skincare product. It serves consumers and healthcare providers with tech-enabled access and integrated fulfillment.

0 investors

RxBio Holdings

0 investors

RxMP Therapeutics

0 investors

RYNE Biotechnology Inc.

0 investors

Rythera Therapeutics

0 investors

S1P Therapeutics

S1P Therapeutics is a preclinical-stage biotechnology company developing drugs that target novel nodes in the S1P pathway for treating kidney and autoimmune diseases. Its aim is to create medicines with less toxicity than existing S1P pathway drugs.

0 investors

S2 Genomics

0 investors

SAB Biotherapeutics

0 investors

Sabik Medical

0 investors

SafeGuard Surgical

SafeGuard Surgical develops a surgical platform centered on LeakGuard, an FDA-cleared stent designed to prevent post-operative complications without requiring removal. The company serves healthcare systems and surgeons seeking to reduce recovery time, complications, and costs.

0 investors

SafePath Medical

SafePath Medical makes the FDA-cleared SafePath Safety Suturing Device, a suturing tool for catheter securement and wound closure designed to prevent needlestick and sharps injuries for healthcare workers. The device is sold to hospitals and, via a federal supply contract, to the VA, DoD, and other federal healthcare facilities in the US.

0 investors

Sage Therapeutics

0 investors

Saghmos Therapeutics

0 investors

Salarius Pharmaceuticals

Decoy Therapeutics is a biotechnology company developing Designable Multi-Antivirals (D-MAVs), peptide conjugate antivirals built on its AI-enabled IMPΒ³ACT platform to target viral mechanisms shared across multiple viruses. Its lead programs are self-administered, nasally inhaled fusion inhibitors for respiratory viruses, including a pan-coronavirus drug for immunocompromised patients and a combined flu/COVID/RSV "tripledemic" antiviral.

0 investors

Salerno Pharmaceuticals

0 investors

Saliogen Therapeutics

SalioGen Therapeutics was a genetic medicine company. The company is no longer operating.

0 investors

SalivIQ Diagnostics

0 investors

Salix Pharmaceuticals

0 investors

Salus Scientific

Salus Scientific designs radiation protection solutions for healthcare providers, with a focus on eliminating occupational hazards in fluoroscopy and medical environments. The company's flagship product addresses the physical strain caused by traditional lead aprons used in medical imaging procedures.

0 investors

Salutaris Medical Devices

0 investors

SanaRx Biotherapeutics

0 investors

Sancilio Pharmaceuticals

0 investors

Sano Chemicals

Sano Chemicals is a clinical-stage drug development company creating new chemical entities (NCEs) as first-in-class treatments for antimicrobial-resistant fungi and bacteria, with additional research into cancer applications. It develops novel drug products aimed at infectious diseases where existing treatments have become ineffective.

0 investors

Sanovas

0 investors

Other sectors & tags